Crestal Bone Loss and Patient Satisfaction of Screw Retained Restoration
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03671668 |
|
Recruitment Status : Unknown
Verified October 2018 by Mohamed saber mohamed ahmed, South Valley University.
Recruitment status was: Not yet recruiting
First Posted : September 14, 2018
Last Update Posted : October 26, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Bone Loss | Other: titanium bases using intra oral luting cement technique | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 30 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | Completely edentulous patients |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | Crestal Bone Loss and Patient Satisfaction of Screw Retained Restoration Using Multi-unit Abutments Versus Intra-oral Luting on Titanium Bases in Implant Supported Complete Overdentures: A Randomized Clinical Trial |
| Estimated Study Start Date : | November 1, 2018 |
| Estimated Primary Completion Date : | September 1, 2019 |
| Estimated Study Completion Date : | September 1, 2019 |
| Arm | Intervention/treatment |
|---|---|
| Active Comparator: Screw retained prosthesis on transmucosal abutments |
Other: titanium bases using intra oral luting cement technique
comparing between screw retained prosthesis constructed on transmucosal abutments versus titanium bases in terms of crestal bone loss and patient satisfaction |
| Experimental: Screw retained prosthesis on titanium bases |
Other: titanium bases using intra oral luting cement technique
comparing between screw retained prosthesis constructed on transmucosal abutments versus titanium bases in terms of crestal bone loss and patient satisfaction |
- Crestal bone loss [ Time Frame: 6 to 12 months ]measuring crestal bone loss around implants using periapical x ray with parallel technique in millemeters
- Patients satisfaction [ Time Frame: 6 to 12 months ]Numerical Rating Scale (NRS) [11-point ordinal scale from 0 (completely dissatisfied) to 10 (completely satisfied)]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | Child, Adult, Older Adult |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Completely edentulous patients
- Patients with completely edentulous ridges have an opposing natural dentition or implant supported overdenture
- Completely edentulous patients (with the above mentioned criteria) who have proper amount of attached gingiva (≥2 mm) or to be created
- Completely edentulous patients (with the above mentioned criteria) who have no history of bruxism
- Completely edentulous patients (with the above mentioned criteria) who were free or controlled diabetic assessed by measuring glycosylated haemoglobin (HbA1c). (lesser than or equal to 6.4 percent )
Exclusion Criteria:
- Patients having a medical condition that absolutely contraindicates implant placement.
- Patients with uncontrolled diabetes, assessed by measuring glycosylated haemoglobin (HbA1c). (greater than to 6.4 percent )
- Potentially uncooperative patients who are not willing to go through the proposed interventions. - Moderate-to-heavy daily smokers* (who report consuming at least 11 cigarettes/day).
- Patients who are having complete lower denture
- Patients who have history of bruxism
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03671668
| Contact: Mohamed Saber Ahmed | 00201068316376 ext 0020 | mohamed.saber@dentistry.cu.edu.eg |
| Responsible Party: | Mohamed saber mohamed ahmed, Assistant lecturer, South Valley University |
| ClinicalTrials.gov Identifier: | NCT03671668 |
| Other Study ID Numbers: |
28905011809519 |
| First Posted: | September 14, 2018 Key Record Dates |
| Last Update Posted: | October 26, 2018 |
| Last Verified: | October 2018 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Bone Diseases, Metabolic Bone Diseases Musculoskeletal Diseases Metabolic Diseases |

